Borderline Disseminated (Intermediate) Cutaneous Leishmaniasis: A Case-based Approach to Diagnosis and Clinical Management in Pediatric Population
Pediatric BDCL presents significant diagnostic and therapeutic challenges due to variable immune responses, clinical presentations and species-related treatment resistance. While meglumine antimoniate and miltefosine showed promising results, amphotericin B was less effective. Further research is needed to establish optimized treatment protocols for pediatric BDCL, considering species-specific responses and pharmacokinetic and pharmacodynamic differences in children.
Authors
- Dora Estripeaut (ORCID: https://orcid.org/0000-0002-2042-0817)
- Juan David Ramírez (ORCID: https://orcid.org/0000-0002-1344-9312)
- Yamilka Díaz (ORCID: https://orcid.org/0000-0002-1651-9670)
- Alberto Paniz‐Mondolfi (ORCID: https://orcid.org/0000-0003-1259-1736)
- Jacqueline Levy
- Carolina Hernández (ORCID: https://orcid.org/0000-0002-9989-4352)
- Milagros Llanos Flores
- José Antonio Suárez (ORCID: https://orcid.org/0000-0001-9407-1624)
- Ruth Garcia-Redondo
- Diego Lozano-Durán
Institutions
- Universidad de Panamá (PA)
- Florida State University-Panama (PA)
- Instituto Conmemorativo Gorgas de Estudios de la Salud (PA)
- Hospital Costa del Sol (ES)
- Saint Thomas Hospital (PA)
- Secretaría Nacional de Ciencia, Tecnología e Innovación (PA)
- Universidad Interamericana de Panamá (PA)
- Hospital del Niño (PA)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/inf.0000000000004761
- Citations
- 1
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.88